ANTI-PD-L1 ANTIBODY FORMULATIONS
The invention provides liquid pharmaceutical formulations comprising an anti-PD-L1 antibody, such as liquid pharmaceutical formulations for subcutaneous administration. The invention also provides methods for making such formulations and methods of using such formulations.
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English |
Published |
09.02.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The invention provides liquid pharmaceutical formulations comprising an anti-PD-L1 antibody, such as liquid pharmaceutical formulations for subcutaneous administration. The invention also provides methods for making such formulations and methods of using such formulations. |
---|---|
Bibliography: | Application Number: US202017783229 |